Form 6-K

0001193125-20-286842.txt : 20201105 0001193125-20-286842.hdr.sgml : 20201105 20201105161826 ACCESSION NUMBER: 0001193125-20-286842 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201105 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectis S.A. CENTRAL INDEX KEY: 0001627281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36891 FILM NUMBER: 201290710 BUSINESS ADDRESS: STREET 1: 8 RUE DE LA CROIX JARRY CITY: PARIS, LLE-DE-FRANCE STATE: I0 ZIP: 75013 BUSINESS PHONE: 33181691600 MAIL ADDRESS: STREET 1: 8 RUE DE LA CROIX JARRY CITY: PARIS, LLE-DE-FRANCE STATE: I0 ZIP: 75013 6-K 1 d59304d6k.htm FORM 6-K Form 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

Date of Report: November 5, 2020

Commission File Number: 001-36891

Cellectis S.A.

(Exact Name of registrant as specified in its charter)

8, rue de la Croix Jarry

75013 Paris, France

+33 1 81 69 16 00

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Combined Shareholders’ Meeting

Cellectis S.A. (the “Company”) held a Combined Ordinary and Extraordinary General Meeting (the “Meeting”) on November 4, 2020. Attached as Exhibit 99.1 hereto are the voting results for the Meeting.

EXHIBIT INDEX


Exhibit		Title

99.1		Voting Results for the Combined Ordinary and Extraordinary General Meeting

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	CELLECTIS S.A.
	(Registrant)

November 5, 2020	By:	/s/ André Choulika
		André Choulika
		Chief Executive Officer

EX-99.1 2 d59304dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

CELLECTIS - GENERAL ASSEMBLY - 11/04/2020

VOTE RESULTS

Ordinary Resolutions


				For					Against					Vote withhold						Shares represented by the votes		Percentage of the share capital represented by the votes			Out of vote voting		Null voting
Nb	Resolution		Result	Votes		%			Votes		%			Votes		%		Total votes		cast		cast			rights		rights		Quorum
1		Appointment of a new board member
1		1	Carried		35 577 640		94,89	%		1 914 142		5,11	%		4 714		—		37 491 782		32 546 332		76,599	%		0		0		76,599	%


Page 1 sur 2		11/04/20

CELLECTIS - GENERAL ASSEMBLY - 11/04/2020

VOTE RESULTS

Extraordinary Resolutions


				For					Against					Vote withhold						Shares represented by the votes		Percentage of the share capital represented by the votes			Out of vote voting		Null voting
Nb	Resolution		Result	Votes		%			Votes		%			Votes		%		Total votes		cast		cast			rights		rights		Quorum
2		Amendment of the age limit applicable to directors, the chairman of the board of directors, the chief executive officer and to the deputy chief executive officers – subsequent amendment of the articles of association
2		2	Carried		37 116 409		99,01	%		371 751		0,99	%		8 336		—		37 488 160		32 546 332		76,599	%		0		0		76,599	%


Page 2 sur 2		11/04/20